CompletedPhase 4

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

United States292 participantsStarted 2024-10-14

Plain-language summary

The purpose of this study is to determine how well multiple CAMPs (Cellular, Acellular and Matrix-Like Products) and Standard of Care work when compared to Standard of Care alone in achieving complete closure of diabetic foot and venous leg ulcers.

Who can participate

Age range18 Years – 98 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ABI ≥ 0.7 and ≤ 1.3;
✓. TBI ≥ 0.6;
✓. TCOM ≥ 40 mmHg;
✓. PVR: biphasic.

Exclusion criteria

✕. ABI between 0.7 and ≤ 1.3;
✕. TBI ≥ 0.6;
✕. TCOM ≥ 40 mmHg;
✕. PVR: biphasic.

What they're measuring

Percentage of ulcers with complete wound closure

Timeframe: 1-12 weeks

Trial details

NCT IDNCT06562296

SponsorCellution Biologics

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-06-11

View on ClinicalTrials.gov More Diabetic Foot Ulcer trials